FEATURES OF THE COURSE OF CORONAVIRUS INFECTION IN PREGNANT WOMEN

Abstract

The article presents the results of a study conducted to investigate the impact of the COVID19 coronavirus infection on the course and outcomes of pregnancy. The study included 222 pregnant women infected with COVID-19 (Group I) and 46 healthy women who comprised the control group (Group II). The results showed that COVID-19 infection has a negative effect on the course and outcomes of pregnancy. In most women, the disease had a mild (52.7%) or moderate (37.8%) course, while in 9.5% of cases it was severe. Among infected women, the incidence of anemia (65.8%), hypertension (25.7%), obesity (21.6%), and preeclampsia (14.9%) was significantly higher. There was also a higher frequency of preterm births (44.7%) and antenatal fetal death (9.2%). Laboratory findings such as elevated levels of D-dimer, fibrinogen, C-reactive protein, ferritin, and creatinine indicated pronounced inflammatory and coagulation processes. COVID-19 infection in pregnant women is characterized by a polymorphic clinical presentation, systemic inflammation, and coagulation disorders. The disease increases the risk of complications for both the mother and the fetus. Regular monitoring of oxygen saturation and an individualized approach to early treatment contribute to improving pregnancy outcomes and reducing associated risks.